Polycystic ovary syndrome in type 2 diabetes: does it predict a more severe phenotype?
In women with type 2 diabetes, a history of polycystic ovary syndrome is associated with an earlier onset of diabetes, higher body mass index, and higher rate of gestational diabetes and pregnancy hypertension.
Volume 106, Issue 5, Pages 1258-1263
Stephanie Y.T. Sim, M.B.B.S., Sian L. Chin, M.B.B.S., Jocelyn L.K. Tan, B.Sc., M.Sc., Suzanne J. Brown, B.Sc., Andrea J. Cussons, M.B.B.S., F.R.A.C.P., Ph.D., Bronwyn G.A. Stuckey, M.B.B.S., F.R.A.C.P.
To examine the prevalence of a history of polycystic ovary syndrome (PCOS) in women with type 2 diabetes (DM2) and to compare metabolic and reproductive outcomes between women with and without PCOS.
Female inpatients age 18–75 years with DM2.
A face-to-face questionnaire was administered.
Main Outcome Measure(s)
Age at diagnosis of diabetes, history of gestational diabetes, family history of diabetes, and reproductive history, fertility history, number of miscarriages, and morbidity in pregnancy.
One hundred seventy-one inpatients with DM2 participated. The prevalence of a history of PCOS was 37%. Women with PCOS had an earlier mean age of diagnosis of DM2 (44.2 vs. 48.8 years), higher recalled peak body mass index (BMI; 43.1 kg/m2 vs. 36.8 kg/m2), higher rate of gestational diabetes (28% vs. 18%), and higher rate of hypertension in pregnancy (40% vs. 22%). Women with PCOS were less likely to have a family history of DM2 than those without PCOS (45% vs. 67%).
A history of PCOS in women with DM2 is associated with earlier onset of DM2, higher BMI, and a more severe phenotype. Since PCOS subjects were less likely to have a family history of DM2, lack of a family history of DM2 in women with PCOS is not reassuring for DM2 risk. We recommend identifying PCOS in early life and intervening to reduce the risk of diabetes and its comorbidities and suboptimal reproductive outcomes.